Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consequences of Positron-Emission-Tomography/Computed Tomography (PET/CT) Based Radiotherapy Treatment Planning for Clinical Outcome in Esophageal Cancer Patients

NCT01156831 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT01156831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01156831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consequences of Positron-Emission-Tomography/Computed Tomography (PET/CT) Based Radiotherapy Treatment Planning for Clinical Outcome in Esophageal Cancer Patients
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
May 31, 2013
Enrollment
115 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasms